Q4 2020 Holdings
Filed 2021-02-16 | 82 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Macrogenics Inc(MGNX) | COM | 556099109 | $100.0K | 4,375,217 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $103.0K | 9,502,383 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $103.4K | 2,150,404 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $105.2K | 1,710,265 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $106.9K | 5,345,631 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $115.4K | 4,736,214 | 0.0% |
| Rocket Pharmaceuticals Inc COM(RCKT) | COM | 77313F106 | $117.1K | 2,136,081 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $118.8K | 18,417,458 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $124.2K | 4,557,867 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $124.2K | 4,179,067 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $127.1K | 3,825,008 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $132.3K | 1,875,000 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $142.9K | 3,593,052 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $149.4K | 4,417,258 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $295.8K | 4,776,548 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $314.5K | 9,011,651 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $344.5K | 5,605,129 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $422.5K | 3,788,564 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $451.8K | 8,685,471 | 0.0% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $8.0M | 564,102 | 0.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.5M | 1,025,641 | 0.6% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $13.5M | 2,499,025 | 0.7% |
| Alector Inc(ALEC) | COM | 014442107 | $24.5M | 1,616,879 | 1.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $32.8M | 1,165,184 | 1.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $39.9M | 6,163,086 | 2.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $45.6M | 1,377,569 | 2.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $59.2M | 3,290,000 | 3.0% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $83.0M | 2,589,904 | 4.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $134.9M | 1,655,447 | 6.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $224.3M | 5,368,451 | 11.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $311.9M | 3,672,872 | 15.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $978.2M | 5,865,338 | 49.6% |